CAM
NVS icon

ClariVest Asset Management’s Novartis NVS Stock Holding History

ClariVest Asset Management’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$2.77K Hold
26
– – ﹤0.01% 490
2024
Q2 		$2.77K Hold
26
– – ﹤0.01% 490
2024
Q1 		$2.49K Hold
26
– – ﹤0.01% 542
2023
Q4 		$2.6K Buy
+26
New +$2.51K ﹤0.01% 516

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClariVest Asset Management's NVS Position: Q3 2024 in Review

ClariVest Asset Management held its Novartis (NVS) position steady in Q3 2024 at 26 shares worth $2.77K. The position accounts for ﹤0.01% of the portfolio, ranked #490.

ClariVest Asset Management first reported a position in NVS in Q4 2023 and has held it in 4 quarters since. 1,312 funds tracked by Wall St. Rank hold NVS as of Q3 2024.

  • ClariVest Asset Management held 26 shares of Novartis worth $2.77K as of Q3 2024.
  • ClariVest Asset Management left its Novartis share count unchanged in Q3 2024.
  • Novartis made up ﹤0.01% of ClariVest Asset Management's portfolio in Q3 2024, its #490 holding.
  • ClariVest Asset Management first reported a position in Novartis in Q4 2023 and has held it in 4 quarters since.
  • 1,312 funds tracked by Wall St. Rank held Novartis as of Q3 2024.

Based on ClariVest Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.